To The Moon

Key Points -Innovation often drives rapid sales growth. -However, sales growth alone rarely tells the full story about a company. For more than a decade, growth stocks have been unstoppable. Abundant access to cheap capital and historically low lending rates have allowed fast-growing businesses to hire, acquire, and put their innovative prowess to work. But for some companies, their growth is just getting started. For the following four under-the-radar small-cap growth stocks, Wall Street expects sales to increase by 707% to as much as 9,406% over the next four years. Bionano Genomics$Bionano Genomics(BNGO)$: Implied sales growth of 1,182% by 2024 First up is small-cap genome analysis company Bionano Genomics (NASDAQ:BNGO). Wall Stree

On August 20th last week, Snowflake$Snowflake(SNOW)$ plunged 11% in intraday trading because of a report by Cleveland Research. Snowflake's new signing growth is slower than in the first quarter, while consumption growth is likely to be flat at most in the first quarter, the report said. As well as increased competition from super enterprises, the company's sales cycle will be prolonged. Although the company recovered lost ground on the same day, it added a prelude to the financial report released this week. In the 22Q2 financial report released on Thursday morning, Beijing time, the company's share price rose by 7.6% that day. Although the stock price increase by voting with your feet is the most intuitive, However, we still noticed that the weak gu